Zolex Therapeutics

Treatment for Drug-resistant Bacterial Infections

Health Tech & Life Sciences
Non Active, Nov 2018
Pre-Funding Tel Aviv-Yafo, Israel Founded 2016
Last updated 2026-06-18
Total raised
$500K
Last: Grant 2016-12
Stage
Pre-Funding
Founded
2016
Headcount
6
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

Zolex Therapeutics is a recently established drug company focusing on the development of new classes of orally active, small-molecular-weight antibiotics that target Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus strains. Zolex Therapeutics is located within the RadBioMed Accelerator at Ramat Hachayal, Tel Aviv, and is led by Dr. Lewis Neville and Dr. Ziv Lifshitz.

Funding history · 1 round · $500K total

2016-12
Grant $500K

Q&A

What is Zolex Therapeutics' primary focus?
Zolex Therapeutics focuses on developing new classes of orally active, small-molecular-weight antibiotics to target Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus strains.
When was Zolex Therapeutics founded?
Zolex Therapeutics was founded in August 2016.
What is the current status of Zolex Therapeutics?
Zolex Therapeutics is currently inactive, as of November 2018.
Where is Zolex Therapeutics headquartered?
Zolex Therapeutics is headquartered in Tel Aviv-Yafo, Israel.
How many employees does Zolex Therapeutics have?
Zolex Therapeutics has 1-10 employees.
What is the total amount of funding Zolex Therapeutics has raised?
Zolex Therapeutics has raised a total of $500,000.
When did Zolex Therapeutics receive its last funding round?
Zolex Therapeutics received a Grant round in December 2016 for $500,000.
Who are the leaders of Zolex Therapeutics?
Zolex Therapeutics is led by Dr. Lewis Neville and Dr. Ziv Lifshitz.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

pharmaceuticalsantibioticspharma-companiesantibodiesdrug-discoverybiopharmaceutical
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2016-8
Employees (exact)6
Status reasonNon Active, Nov 2018